Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2005 2
2006 2
2007 2
2008 1
2009 2
2010 1
2011 1
2012 1
2013 3
2014 1
2015 5
2016 1
2017 2
2018 3
2019 3
2020 8
2021 2
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Radioimmunoconjugates for the treatment of cancer.
Kraeber-Bodéré F, Bodet-Milin C, Rousseau C, Eugène T, Pallardy A, Frampas E, Carlier T, Ferrer L, Gaschet J, Davodeau F, Gestin JF, Faivre-Chauvet A, Barbet J, Chérel M. Kraeber-Bodéré F, et al. Among authors: ferrer l. Semin Oncol. 2014 Oct;41(5):613-22. doi: 10.1053/j.seminoncol.2014.07.004. Epub 2014 Jul 22. Semin Oncol. 2014. PMID: 25440606 Review.
Radiomics for radiation oncologists: are we ready to go?
Vaugier L, Ferrer L, Mengue L, Jouglar E. Vaugier L, et al. Among authors: ferrer l. BJR Open. 2020 Mar 25;2(1):20190046. doi: 10.1259/bjro.20190046. eCollection 2020. BJR Open. 2020. PMID: 33178967 Free PMC article. Review.
PSMA Is Not Specific to Prostate Cancer.
Ah-Thiane L, Ferrer L, Rousseau C. Ah-Thiane L, et al. Among authors: ferrer l. J Nucl Med. 2023 Aug;64(8):1326. doi: 10.2967/jnumed.123.265720. Epub 2023 Jun 22. J Nucl Med. 2023. PMID: 37348920 No abstract available.
Reoxygenation during radiotherapy in intermediate-risk prostate cancer.
Supiot S, Rousseau C, Dore M, Chèze-Le-Rest C, Kandel-Aznar C, Potiron V, Guerif S, Paris F, Ferrer L, Campion L, Meingan P, Delpon G, Hatt M, Visvikis D. Supiot S, et al. Among authors: ferrer l. Radiother Oncol. 2019 Apr;133:16-19. doi: 10.1016/j.radonc.2018.12.022. Epub 2019 Jan 12. Radiother Oncol. 2019. PMID: 30935573
Radioimmunotherapy of B-Cell Non-Hodgkin's Lymphoma.
Bodet-Milin C, Ferrer L, Pallardy A, Eugène T, Rauscher A, Alain Faivre-Chauvet, Barbet J, Kraeber-Bodéré F. Bodet-Milin C, et al. Among authors: ferrer l. Front Oncol. 2013 Jul 11;3:177. doi: 10.3389/fonc.2013.00177. eCollection 2013. Front Oncol. 2013. PMID: 23875170 Free PMC article.
Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.
Le Thiec M, Testard A, Ferrer L, Guillerminet C, Morel O, Maucherat B, Rusu D, Girault S, Lacombe M, Hamidou H, Meyer VG, Rio E, Hiret S, Kraeber-Bodéré F, Campion L, Rousseau C. Le Thiec M, et al. Among authors: ferrer l. Cancers (Basel). 2020 Jun 9;12(6):1512. doi: 10.3390/cancers12061512. Cancers (Basel). 2020. PMID: 32527039 Free PMC article.
50 results